BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 25985145)

  • 1. Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction.
    Su Q; Nyi TS; Li L
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD009503. PubMed ID: 25985145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction.
    Aung Naing K; Li L; Su Q; Wu T
    Cochrane Database Syst Rev; 2013 Jun; (6):CD009503. PubMed ID: 23736949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis.
    Niu X; Zhang J; Bai M; Peng Y; Sun S; Zhang Z
    BMC Cardiovasc Disord; 2018 Jan; 18(1):3. PubMed ID: 29320987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-blockers for suspected or diagnosed acute myocardial infarction.
    Safi S; Sethi NJ; Nielsen EE; Feinberg J; Jakobsen JC; Gluud C
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012484. PubMed ID: 31845756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Adenosine in Patients With Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A PRISMA-Compliant Meta-Analysis.
    Gao Q; Yang B; Guo Y; Zheng F
    Medicine (Baltimore); 2015 Aug; 94(32):e1279. PubMed ID: 26266362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete versus culprit-only revascularisation in ST elevation myocardial infarction with multi-vessel disease.
    Bravo CA; Hirji SA; Bhatt DL; Kataria R; Faxon DP; Ohman EM; Anderson KL; Sidi AI; Sketch MH; Zarich SW; Osho AA; Gluud C; Kelbæk H; Engstrøm T; Høfsten DE; Brennan JM
    Cochrane Database Syst Rev; 2017 May; 5(5):CD011986. PubMed ID: 28470696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of verapamil and adenosine in an adjunct to tirofiban on resolution and prognosis of noreflow phenomenon in patients with acute myocardial infarction.
    Faruk Akturk I; Arif Yalcin A; Biyik I; Sarikamis C; Turhan Caglar N; Erturk M; Celik O; Uzun F; Murat Caglar I; Oner E
    Minerva Cardioangiol; 2014 Oct; 62(5):389-97. PubMed ID: 24699550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intracoronary nitroprusside in preventing no reflow phenomenon during primary percutaneous coronary intervention: a meta-analysis.
    Zhao S; Qi G; Tian W; Chen L; Sun Y
    J Interv Cardiol; 2014 Aug; 27(4):356-64. PubMed ID: 25041036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of monocyte chemoattractant protein-1 to predict no-reflow and three-year mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Buyukkaya E; Poyraz F; Karakas MF; Kurt M; Akcay AB; Akpinar I; Motor S; Turak O; Ozturk OH; Sen N; Akpek M; Kaya MG; Gibson CM
    Am J Cardiol; 2013 Jul; 112(2):187-93. PubMed ID: 23601576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verapamil reverses myocardial no-reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction.
    Fu Q; Lu W; Huang YJ; Wu Q; Wang LG; Wang HB; Jiang SZ; Wang YJ
    Cell Biochem Biophys; 2013; 67(3):911-4. PubMed ID: 23559273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotics for secondary prevention of coronary heart disease.
    Sethi NJ; Safi S; Korang SK; Hróbjartsson A; Skoog M; Gluud C; Jakobsen JC
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD003610. PubMed ID: 33704780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term effect of verapamil on coronary no-reflow associated with percutaneous coronary intervention in patients with acute coronary syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Su Q; Li L; Liu Y
    Clin Cardiol; 2013 Aug; 36(8):E11-6. PubMed ID: 23749333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-eluting stents versus bare-metal stents for acute coronary syndrome.
    Feinberg J; Nielsen EE; Greenhalgh J; Hounsome J; Sethi NJ; Safi S; Gluud C; Jakobsen JC
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012481. PubMed ID: 28832903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-blockers in patients without heart failure after myocardial infarction.
    Safi S; Sethi NJ; Korang SK; Nielsen EE; Feinberg J; Gluud C; Jakobsen JC
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012565. PubMed ID: 34739733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic lidocaine for myocardial infarction.
    Martí-Carvajal AJ; Simancas-Racines D; Anand V; Bangdiwala S
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD008553. PubMed ID: 26295202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
    Uhlig K; Efremov L; Tongers J; Frantz S; Mikolajczyk R; Sedding D; Schumann J
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD009669. PubMed ID: 33152122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent era.
    Fanning JP; Nyong J; Scott IA; Aroney CN; Walters DL
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD004815. PubMed ID: 27226069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials.
    Singh M; Shah T; Khosla K; Singh P; Molnar J; Khosla S; Arora R
    Ther Adv Cardiovasc Dis; 2012 Jun; 6(3):101-14. PubMed ID: 22562999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dipyridamole versus verapamil for treatment of no-reflow during primary angioplasty.
    Tanzilli G; Greco C; Pasceri V; Pelliccia F; Arrivi A; Placanica A; Mangieri E
    Catheter Cardiovasc Interv; 2010 Nov; 76(6):787-93. PubMed ID: 20737584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.